Recombinant protein expression systems have not changed fundamentally in 30 years. E. coli expression is cheap but yields non-glycosylated, sometimes misfolded proteins that require refolding optimization. HEK-293 and CHO mammalian cell systems produce properly glycosylated proteins but at significantly higher cost and batch variability. For growth factors and cytokines, where receptor binding affinity is directly coupled to glycosylation state and 3D structure, neither system is ideal.
MycoFold was built to solve this. Their platform uses engineered Komagataella phaffii (formerly Pichia pastoris) yeast as the expression chassis, a eukaryotic system that provides mammalian-type post-translational modifications, chaperoned folding for complete 3D protein structures, and consistent lot-to-lot performance that yeast fermentation enables by design. Combined with AI- and ML-guided sequence optimization to maximize receptor binding affinity, the result is a recombinant protein that outperforms both E. coli and HEK-293-based competitors in head-to-head activity assays.
The K. phaffii Expression Advantage
The choice of expression host is not a procurement detail, it determines what you get in the vial. MycoFold's technology platform combines three elements that together deliver a meaningfully different product:
Head-to-Head Performance Data
Scientific claims about recombinant protein quality need to be grounded in data. MycoFold benchmarks every product lot against the leading E. coli-expressed and HEK-293-expressed competitor versions using standardized bioassays calibrated against WHO or NIBSC international standards. The results are consistent.
As a concrete example: MycoFold's rHu M-CSF demonstrated a specific activity greater than 3.13 × 10⁵ IU/mg against the WHO Standard NIBSC 21/308, and outperformed both a leading E. coli-expressed and a leading HEK-293-expressed competitor version in dose-dependent induction of the M-NFS-60 cell line, as assessed by PrestoBlue™ Cell Viability luminescence assay.
Available Products: Growth Factors & Cytokines
MycoFold's current catalog focuses on human recombinant growth factors and cytokines, proteins where bioactivity, structural integrity, and lot consistency are most consequential to experimental outcome. All products ship lyophilized with a 24-month shelf life, ambient temperature shipping, and lot-specific CoA.
For immunology and drug discovery applications where cytokine bioactivity directly determines assay readout, the expression host is not a secondary specification, it is the experiment. A growth factor that induces 30% more proliferation per microgram is not just a better product; it changes the dose-response curve, the EC50 calculation, and the conclusion of any screen built around it.
Browse MycoFold Proteins on eBioHippo
AI-engineered growth factors and cytokines in ≥98% purity, with lot-specific CoA and 24-month shelf life.
View Protein Catalog → Compare Cytokines